Corbion Past Earnings Performance
Past criteria checks 5/6
Corbion has been growing earnings at an average annual rate of 11.4%, while the Chemicals industry saw earnings declining at 3.8% annually. Revenues have been growing at an average rate of 10.7% per year. Corbion's return on equity is 10.6%, and it has net margins of 5.6%.
Key information
11.4%
Earnings growth rate
11.4%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 10.7% |
| Return on equity | 10.6% |
| Net Margin | 5.6% |
| Next Earnings Update | 27 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Corbion makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,439 | 80 | 179 | 47 |
| 31 Mar 24 | 1,442 | 77 | 179 | 46 |
| 31 Dec 23 | 1,444 | 73 | 178 | 46 |
| 30 Sep 23 | 1,380 | 57 | 178 | 47 |
| 30 Jun 23 | 1,412 | 54 | 180 | 48 |
| 31 Mar 23 | 1,435 | 72 | 176 | 48 |
| 31 Dec 22 | 1,458 | 90 | 171 | 47 |
| 30 Sep 22 | 1,350 | 76 | 167 | 46 |
| 30 Jun 22 | 1,243 | 63 | 162 | 46 |
| 31 Mar 22 | 1,157 | 70 | 158 | 44 |
| 31 Dec 21 | 1,071 | 78 | 155 | 43 |
| 30 Sep 21 | 1,040 | 97 | 149 | 41 |
| 30 Jun 21 | 1,010 | 116 | 144 | 40 |
| 31 Mar 21 | 998 | 95 | 142 | 38 |
| 31 Dec 20 | 987 | 73 | 140 | 37 |
| 30 Sep 20 | 992 | 49 | 143 | 35 |
| 30 Jun 20 | 997 | 24 | 147 | 32 |
| 31 Mar 20 | 987 | 25 | 147 | 33 |
| 31 Dec 19 | 976 | 26 | 146 | 35 |
| 30 Sep 19 | 953 | 37 | 141 | 38 |
| 30 Jun 19 | 930 | 48 | 135 | 42 |
| 31 Mar 19 | 914 | 51 | 132 | 41 |
| 31 Dec 18 | 897 | 54 | 129 | 39 |
| 30 Sep 18 | 883 | 61 | 128 | 37 |
| 30 Jun 18 | 869 | 69 | 126 | 35 |
| 31 Mar 18 | 880 | 77 | 126 | 34 |
| 31 Dec 17 | 892 | 85 | 126 | 33 |
| 30 Sep 17 | 905 | 87 | 128 | 32 |
| 30 Jun 17 | 918 | 89 | 130 | 32 |
| 31 Mar 17 | 914 | 95 | 128 | 31 |
| 31 Dec 16 | 911 | 102 | 126 | 31 |
| 30 Sep 16 | 917 | 103 | 124 | 33 |
| 30 Jun 16 | 922 | 104 | 122 | 34 |
| 31 Mar 16 | 920 | 91 | 122 | 33 |
| 31 Dec 15 | 918 | 78 | 121 | 33 |
| 30 Sep 15 | 885 | 45 | 119 | 32 |
| 30 Jun 15 | 851 | 13 | 118 | 31 |
| 31 Mar 15 | 811 | -4 | 119 | 32 |
| 31 Dec 14 | 770 | -21 | 121 | 32 |
| 30 Sep 14 | 757 | -15 | 119 | 30 |
| 30 Jun 14 | 744 | -9 | 116 | 28 |
| 31 Mar 14 | 744 | -3 | 117 | 26 |
| 31 Dec 13 | 744 | 2 | 117 | 25 |
Quality Earnings: CRBNA has high quality earnings.
Growing Profit Margin: CRBNA's current net profit margins (5.6%) are higher than last year (3.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRBNA's earnings have grown by 11.4% per year over the past 5 years.
Accelerating Growth: CRBNA's earnings growth over the past year (49.2%) exceeds its 5-year average (11.4% per year).
Earnings vs Industry: CRBNA earnings growth over the past year (49.2%) exceeded the Chemicals industry -36.8%.
Return on Equity
High ROE: CRBNA's Return on Equity (10.6%) is considered low.